Beam Therapeutics Inc. (BEAM)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS07373V1052
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Beam Therapeutics Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:48. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 23 Feb 2027 08:00 | -1.22 | — | — | Upcoming |
| 03 Nov 2026 07:00 | -1.17 | -1.28 | -9.4% | Miss |
| 04 Aug 2026 07:00 | -1.13 | -1.18 | -4.8% | Miss |
| 07 May 2026 07:00 | -1.01 | -0.91 | +10.1% | Beat |
| 24 Feb 2026 07:00 | -1.12 | 2.33 | +309.0% | Beat |
| 04 Nov 2025 07:00 | -1.01 | -1.10 | -9.0% | Miss |
| 05 Aug 2025 07:00 | -1.09 | -1.00 | +8.4% | Beat |
| 06 May 2025 07:00 | -1.17 | -1.24 | -5.9% | Miss |
| 25 Feb 2025 07:00 | -1.22 | -1.09 | +10.3% | Beat |
| 05 Nov 2024 06:00 | -1.18 | -1.17 | +0.9% | In line |
| 06 Aug 2024 07:00 | -1.12 | -1.11 | +0.7% | In line |
| 07 May 2024 06:00 | -1.39 | -1.21 | +12.9% | Beat |
| 27 Feb 2024 06:00 | -0.71 | 1.73 | +343.6% | Beat |
| 08 Nov 2023 06:00 | -1.27 | -1.22 | +3.7% | Beat |
| 08 Aug 2023 07:00 | -1.38 | -1.08 | +21.6% | Beat |
| 10 May 2023 06:00 | -1.30 | -1.33 | -2.0% | Miss |
| 28 Feb 2023 06:00 | -1.34 | -0.54 | +59.6% | Beat |
| 07 Nov 2022 07:00 | -1.09 | -1.56 | -43.2% | Miss |
| 09 Aug 2022 06:00 | -1.02 | -1.02 | +0.4% | In line |
| 09 May 2022 06:00 | -1.34 | -1.01 | +24.4% | Beat |
| 28 Feb 2022 06:00 | -0.94 | -0.95 | -1.1% | Miss |
| 08 Nov 2021 06:00 | -0.72 | -0.42 | +41.9% | Beat |
| 10 Aug 2021 06:00 | -0.74 | -1.23 | -66.8% | Miss |
| 11 May 2021 06:00 | -0.75 | -3.35 | -344.4% | Miss |
| 15 Mar 2021 06:00 | -0.68 | -1.69 | -147.5% | Miss |
| 10 Nov 2020 06:00 | -0.54 | -0.69 | -27.6% | Miss |
| 12 Aug 2020 06:00 | -0.51 | -0.69 | -34.1% | Miss |
| 12 May 2020 16:00 | -0.48 | -1.03 | -114.2% | Miss |
| 30 Mar 2020 17:00 | -0.49 | -0.35 | +28.6% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 139.7M | +120.0% | -80M | -57.2% | -0.81 | +82.3% | -360M |
| 2024 | 63.5M | -83.2% | -376.7M | -593.1% | -4.58 | -166.3% | -356.2M |
| 2023 | 377.7M | +520.0% | -132.5M | -35.1% | -1.72 | +58.4% | -182.9M |
| 2022 | 60.9M | — | -289.1M | -474.5% | -4.13 | — | -26.4M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 27.45 | 28.00 | 23.47 | 23.68 | -13.04% | 16,788,771 | |
| Oct 2026 | 24.24 | 29.76 | 23.16 | 27.23 | +11.37% | 42,034,000 | |
| Sep 2026 | 28.82 | 30.18 | 22.67 | 24.45 | -16.92% | 40,942,200 | |
| Aug 2026 | 25.55 | 31.48 | 24.67 | 29.43 | +15.32% | 34,753,700 | |
| Jul 2026 | 34.64 | 38.26 | 24.67 | 25.52 | -25.64% | 51,626,000 | |
| Jun 2026 | 32.17 | 36.88 | 28.30 | 34.32 | +4.22% | 49,816,800 | |
| May 2026 | 30.11 | 34.38 | 25.87 | 32.93 | +8.57% | 40,255,300 | |
| Apr 2026 | 24.02 | 32.48 | 23.44 | 30.33 | +27.28% | 44,947,200 | |
| Mar 2026 | 27.28 | 28.96 | 21.63 | 23.83 | -16.27% | 47,282,600 | |
| Feb 2026 | 27.51 | 34.20 | 24.30 | 28.46 | +3.04% | 31,588,900 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Beam Therapeutics: Market Selling Promising Data Readouts Doesn't Add Up (opens in a new tab) SeekingAlpha · 12 Nov 2026 12:50
- BEAM Stock Falls 7% Despite Meeting Primary Endpoints in SCD Study (opens in a new tab) Zacks · 11 Nov 2026 17:06
- Wedbush Maintains Outperform on Beam Therapeutics, Raises Price Target to $33 (opens in a new tab) Benzinga · 11 Nov 2026 10:12
- Beam Therapeutics (BEAM) Clears A Key Trial As The Undervalued Case Faces A Test (opens in a new tab) Simply Wall St. · 11 Nov 2026 00:16
- Beam’s base editing therapy for sickle cell hits goal in pivotal trial (opens in a new tab) BioPharma Dive · 10 Nov 2026 17:06
- Beam Therapeutics to seek approval of SCD cell therapy after trial success (opens in a new tab) Clinical Trials Arena · 10 Nov 2026 17:05
- Beam Therapeutics Announces Positive Topline Pivotal Data from BEACON Phase 1/2 Trial of Risto-cel in Patients with Sickle Cell Disease (opens in a new tab) 10 Nov 2026 12:00
- Guggenheim Maintains Buy on Beam Therapeutics, Lowers Price Target to $51 (opens in a new tab) Benzinga · 05 Nov 2026 12:10
- Beam Therapeutics Inc. (BEAM) Reports Q3 Loss, Misses Revenue Estimates (opens in a new tab) Zacks · 03 Nov 2026 12:15
- Why Beam Therapeutics Stock Is Up 15.6% And What's Next (opens in a new tab) Simply Wall St. · 29 Oct 2026 10:14
- Beam Therapeutics (BEAM) Moves 15.6% Higher: Will This Strength Last? (opens in a new tab) Zacks · 29 Oct 2026 07:50
- BEAM Stock Climbs On First Look At One-Time GSDIa Gene Fix; H.C. Wainwright Sees Further 200% Upside (opens in a new tab) Stocktwits · 27 Oct 2026 19:21
- Beam Therapeutics Reports Early BEAM-301 Gains in GSD1a Fasting Tolerance (opens in a new tab) MarketBeat · 27 Oct 2026 15:05
- Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead? (opens in a new tab) Motley Fool · 18 Oct 2026 02:20
- Will IP Theft Allegations Against YolTech and Serapha Bio Change Beam Therapeutics' (BEAM) Narrative (opens in a new tab) Simply Wall St. · 01 Oct 2026 02:23
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 24.03 USD
- Market cap
- 2.5B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow BEAM and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.